I make a donation
I make a donation
Terminée
objectif
Usefullness of geriatric evaluation to predict mortality, functional prognosis and the quality of life after percutaneous implant of a valvular aortic prosthesis in patients aged over 75.
date de réalisation
2015
nombre de patients
500
nombre de centres participants
14 TAVI implant centers and 13 geriatric centers in France
type de financement
Public (AOM)
Référence
NCT02424370
Geriatric Evaluation to Predict Mortality and Functional Recovery After Trans Aortic Valve Implantation (EVA-G-TAVI)
Transcutaneous trans-aortic valve replacement (TAVR) is now a common procedure to treat symptomatic aortic stenosis. Although as effective and safe as surgical aortic valve replacement, it is still restricted to high surgical risk patient who are frail. The aim of the TAVI-EVA is to identify geriatric biomarkers that may help to predict survival and functional recovery after TAVR.
source clinicaltrials.gov
En cours
En cours
En cours
